SCD and ovarian carcinoma: We found that suppression of SREBF2 in ovarian cancers results in down-regulation of cholesterogenic target genes such as the DHCR7, while induction of SREBF1 is associated with increased expression of lipid synthesis genes such as the SCD1, which was found highly elevated.